Wednesday, June 22nd, 2016 - RnR Market Research

The analysts forecast global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.

The following companies are the key players in the Global Ulcerative Colitis Market: AbbVie, Janssen Biotech, Merck, and Takeda Pharmaceuticals. Other prominent vendors in the market are: Abbott, Ajinomoto Pharmaceuticals, Amgen, Arena Pharmaceuticals, AstraZeneca, Astellas Pharma, Avaxia Biologics, BioLineRx, Celgene, Cosmo Pharmaceuticals, Eisai, Ferring Pharmaceuticals, Galapagos, Genentech, Gilead Sciences, GlaxoSmithKline, Hutchison Medi Pharma, Immune Pharmaceuticals, InDex Pharmaceuticals, Kaken Pharmaceutical, Kissei Pharmaceutical, Kyowa Hakko Kirin, Lipid Therapeutics, Meda, Mitsubishi Tanabe, Mochida Pharmaceutical, Morphotek, Nestlé, Pfizer, Procter & Gamble, Qu Biologics, Receptos, Salix Pharmaceuticals, Shield Therapeutics, Shire Pharmaceuticals, Sterna Biologicals, Tillotts Pharma, TopiVert, UCB, and Zeria Pharmaceutical.

Order a copy of report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=542930

According to the ulcerative colitis market key driver for market growth is the increase in patient assistance programs. Patients who cannot afford costly treatments are provided financial assistance by state and federal agencies such as Medicaid, Medicare, and Social Security in the US. People can also apply for free medications or financial co-pay assistance for the drug Humira through AbbVie's patient assistance program. According to the Humira Complete Savings Card, the drug can be obtained for as low as $5 per month. Similarly, Janssen Pharmaceuticals has initiated programs such as JanssenAccessOne and RemiStart.

The global ulcerative colitis market noteworthy trend to watch for in the pharmaceutical industry is the rising use of biologics. Biologics, available as either intravenous or subcutaneous injections, are increasingly becoming the treatment of choice for ulcerative colitis. They act by either blocking the interleukins or the tumor necrosis factor (TNF)-alpha. Etrolizumab, being developed by Genentech (Roche), and Stelara (ustekinumab), developed by Janssen Pharmaceuticals, are prominent biologics that are under investigation for the treatment of ulcerative colitis and are expected to be launched in the market during the forecast period

Inquire more about Global Ulcerative Colitis Market 2016-2020 report at @  http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=542930

Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.

Further, the report states that expiring patents for many drugs will affect the bottom line for manufacturers and in turn, have an adverse impact on market growth.

File Library

Contact Profile

RnR Market Research


About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed


Ritesh Tiwari
P: + 1 888 391 5441
W: www.rnrmarketresearch.com/

Keywords

AbbVie, Janssen Biotech, Merck, Takeda Pharmaceuticals, Abbott, Ajinomoto, Amgen, Arena, AstraZeneca, Global Ulcerative Colitis Market Driver 2016, Ulcerative Colitis industry, Market Research Reports, Ulcerative Colitis Market analysis, Ulcerative Coliti

Categories

Newsrooms

Sharing

More Formats